Calycosin Targets the CYP1B1 ‐ AKT / SP1 ‐ GPX4 Axis to Modulate Ferroptosis in Colorectal Carcinogenesis
Phytotherapy Research · 2026-02 · 40 (2) · 721-736
DOI: 10.1002/ptr.70172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 06.01.2026. Verfasst von Lihan Bie und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of C…. Hauptthemen laut MEDLINE: Ferroptosis, Colorectal Neoplasms, Isoflavones, Cytochrome P-450 CYP1B1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Scientific Research Program of Shanghai Pudong New Area Health Commission.
Abstract (Originalsprache)
Calycosin, a natural flavonoid small‐molecule compound derived from traditional Chinese medicine, has demonstrated remarkable pharmacological activity in the field of cancer therapy. This study systematically elucidates the molecular mechanisms of Calycosin in colorectal cancer (CRC) treatment through integrated in vivo and in vitro experiments. In vivo experiments revealed that Calycosin effectively inhibits subcutaneous tumor growth in CRC‐bearing mice. In vitro assays and transcriptome sequencing confirmed that Calycosin effectively suppresses migration, invasion, epithelial‐mesenchymal transition (EMT), and induces ferroptosis in human CRC cells, thereby inhibiting malignant tumor behaviors. Cellular Thermal Shift Assay (CETSA) and site‐directed mutagenesis experiments first identified cytochrome P450 1B1 (CYP1B1) and Gly‐329 as critical binding targets and sites for Calycosin. Functional studies showed that CYP1B1 knockdown in vitro and in vivo suppresses GPX4 expression and enhances ferroptosis in CRC cells. Mechanistically, CYP1B1 activates the AKT/SP‐1 signaling pathway to upregulate GPX4 expression, thereby modulating colorectal carcinogenesis and progression. In summary, this study first unveils the crucial role of Calycosin and the CYP1B1‐AKT/SP1‐GPX4 regulatory axis in CRC ferroptosis, providing novel theoretical foundations for targeted therapy using traditional Chinese medicine‐derived small molecules against colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
- Department of Clinical Laboratory, Yangpu Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.
- School of Medicine, Anhui University of Science and Technology, Huainan, Anhui, People's Republic of China.
ORCID-Profile: Chengshan He, Zheng Xu
Förderung
- The Scientific Research Program of Shanghai Pudong New Area Health Commission
Zitieren
APA
Bie, L., Lei, X., Wu, D., Zhang, Y., He, C., Liu, L., Zhou, J., Zhou, X., Lu, Y., & Xu, Z. (2026). Calycosin Targets the CYP1B1 ‐ AKT / SP1 ‐ GPX4 Axis to Modulate Ferroptosis in Colorectal Carcinogenesis. Phytotherapy Research, 40(2), 721-736. https://doi.org/10.1002/ptr.70172
Vancouver
Bie L, Lei X, Wu D, Zhang Y, He C, Liu L, et al. Calycosin Targets the CYP1B1 ‐ AKT / SP1 ‐ GPX4 Axis to Modulate Ferroptosis in Colorectal Carcinogenesis. Phytotherapy Research. 2026;40(2):721-736. doi:10.1002/ptr.70172
BibTeX
@article{Bie2026,
author = {Bie, Lihan and Lei, Xin and Wu, Di and Zhang, Yang and He, Chengshan and Liu, Luyao and Zhou, Jiawei and Zhou, Xin and Lu, Yingying and Xu, Zheng},
title = {Calycosin Targets the CYP1B1 ‐ AKT / SP1 ‐ GPX4 Axis to Modulate Ferroptosis in Colorectal Carcinogenesis},
journal = {Phytotherapy Research},
year = {2026},
volume = {40},
number = {2},
pages = {721--736},
doi = {10.1002/ptr.70172}
}
EUVIMED